Literature DB >> 9815222

Impairment of the mucosal immune system: IgA and IgM cleavage detected in vaginal washings of a subgroup of patients with bacterial vaginosis.

S Cauci1, R Monte, S Driussi, P Lanzafame, F Quadrifoglio.   

Abstract

The integrity of the immunoglobulins in vaginal washings of patients with bacterial vaginosis was examined to answer the question of the lack of immune response against Gardnerella vaginalis cytolysin. Clinically diagnosed patients (n=100) were recruited and their vaginal washings examined by Western blotting. Many showed IgA and IgM partially or extensively degraded. According to the degradation pattern, the patients were subdivided into 4 subsets, from intact (score 0) to completely degraded IgA (score +3). Statistical analysis of the data showed a correlation between IgA degradation and absence of immune response to G. vaginalis cytolysin. The extent of IgA degradation correlated also with the sialidase (but not with the prolidase) activity level. All women showed intact IgG and human serum albumin and no trypsin-like activity. Patients with bacterial vaginosis having high sialidase activity and extensive IgA degradation in their secretions could incur more dangerous infections and adverse pregnancy outcomes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815222     DOI: 10.1086/314505

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Recurrent Bacterial Vaginosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

Review 2.  Life in the littoral zone: lactobacilli losing the plot.

Authors:  P Hay
Journal:  Sex Transm Infect       Date:  2005-04       Impact factor: 3.519

3.  Validation of a gastrointestinal explant system for measurement of mucosal antibody production.

Authors:  G A Losonsky; G T Fantry; M Reymann; Y Lim
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

4.  Prevalence of bacterial vaginosis and vaginal flora changes in peri- and postmenopausal women.

Authors:  Sabina Cauci; Silvia Driussi; Davide De Santo; Paola Penacchioni; Teresa Iannicelli; Paolo Lanzafame; Francesco De Seta; Franco Quadrifoglio; Domenico de Aloysio; Secondo Guaschino
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

5.  Selecting anti-microbial treatment of aerobic vaginitis.

Authors:  Gilbert G G Donders; Katerina Ruban; Gert Bellen
Journal:  Curr Infect Dis Rep       Date:  2015-05       Impact factor: 3.725

6.  Hydrolysis of secreted sialoglycoprotein immunoglobulin A (IgA) in ex vivo and biochemical models of bacterial vaginosis.

Authors:  Warren G Lewis; Lloyd S Robinson; Justin Perry; Jennifer L Bick; Jeffrey F Peipert; Jenifer E Allsworth; Amanda L Lewis
Journal:  J Biol Chem       Date:  2011-12-01       Impact factor: 5.157

7.  Molecular definition of vaginal microbiota in East African commercial sex workers.

Authors:  John J Schellenberg; Matthew G Links; Janet E Hill; Tim J Dumonceaux; Joshua Kimani; Walter Jaoko; Charles Wachihi; Jane Njeri Mungai; Geoffrey A Peters; Shaun Tyler; Morag Graham; Alberto Severini; Keith R Fowke; T Blake Ball; Francis A Plummer
Journal:  Appl Environ Microbiol       Date:  2011-04-29       Impact factor: 4.792

8.  Mannose binding lectin and C3 act as recognition molecules for infectious agents in the vagina.

Authors:  V Pellis; F De Seta; S Crovella; F Bossi; R Bulla; S Guaschino; O Radillo; P Garred; F Tedesco
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

9.  Vaginal Immunity in Bacterial Vaginosis.

Authors:  Sabina Cauci
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

10.  Determination of immunoglobulin A against Gardnerella vaginalis hemolysin, sialidase, and prolidase activities in vaginal fluid: implications for adverse pregnancy outcomes.

Authors:  Sabina Cauci; Poul Thorsen; Diana E Schendel; Annie Bremmelgaard; Franco Quadrifoglio; Secondo Guaschino
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.